Search for: "Eli Lilly " Results 1261 - 1280 of 2,131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2023, 6:59 am by Aparajita Lath
This version of insulin is expected to be interchangeable with popular brand-name insulins – Sanofi’s Lantus, Eli Lilly’s Humalog and Novo Nordisk’s Novolog. [read post]
28 Sep 2023, 12:40 pm by Tom Lamb
The condition, known as ileus, can be life threatening and is already listed as a potential side effect on the labels of Eli Lilly’s diabetes drug Mounjaro and Novo’s weight-loss therapy Wegovy, which is the same formulation as Ozempic, just in a higher dose. [read post]
14 Nov 2007, 8:59 pm
Sun Strattera:  Eli Lilly v. [read post]
24 Jan 2023, 7:59 pm by Kurt R. Karst
 NAD’s inquiry, brought about by a complaint from Eli Lilly (which markets a competitive drug, Verzenio (abemaciclib)), evaluated both express and implied claims made by Novartis to healthcare professionals and consumers that patients with HR+/HER2- metastatic breast cancer will live longer taking Kisqali than with other available treatments, including Verzenio. [read post]
2 May 2014, 10:23 am by Ronald V. Miller, Jr.
., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
2 Feb 2010, 1:02 pm by Carey, Danis & Lowe
The FDA cited that study in its letter informing drug maker Eli Lilly about the label order. [read post]
6 Feb 2010, 5:06 am by Ray Mullman
Lilly agreed to pay $1.4 billion in a related civil settlement. [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings) (Hal… [read post]
10 Feb 2010, 4:47 pm
- UK: EWCA dismisses Human Genome Sciences appeal against decision finding invalidity; invention not ‘susceptible of industrial application’: Eli Lilly v Human Genome Sciences Inc (EPLAW) (IPKat) Nuvigil (Armodafinil) – US: Patent infringement complaints filed in Colorado and Delaware following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Cephalon's Nuvigil: Cephalon, Inc. et al. v. [read post]
18 May 2011, 12:33 am by Marie Louise
  Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
10 Sep 2018, 1:25 am by Kluwer Patent Blog
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
10 Sep 2018, 1:20 am by Kluwer Patent blogger
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
6 Nov 2008, 3:08 am
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
10 Jul 2017, 1:00 am by Matrix Legal Support Service
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
7 Jun 2009, 2:15 pm
Eli Lilly & Co., 560 F.3d 1366, 1380 (Fed. [read post]
26 Aug 2009, 6:12 am
(Korea IP Law Blog) US: Senate Agriculture/FDA Appropriations Bill amendment seeks to streamline development and regulation of products for rare and neglected diseases (FDA Law Blog) US: Professor Grabowski’s economic analysis of data exclusivity for follow-on biologic drugs (Patent Docs) US: Follow-on biologics news briefs: President Obama wants to speed up introduction of generic drugs; biosimilars pose ‘limited threat’; Amgen CEO says biologic manufacturers will… [read post]
19 Mar 2007, 7:01 am
Judges here managed the multidistrict litigation involving Prozac manufactured by the Eli Lilly Co. of Indianapolis, McKinney noted. [read post]
7 Jan 2014, 5:19 pm by Dr. Shezad Malik
Tradjenta (linagliptin) is manufactured by Eli Lilly and Boehringer Ingelheim and approved for sale in 2011. [read post]
7 Aug 2010, 4:46 am by Dennis Crouch
Court Decisions: District Court Opinion Original Panel Decision En Banc Order Party Briefs: TheraSense (Abbott) Opening Brief: TheraSense.pdf (608 KB) Amicus Brief filed in Support of TheraSense Sanofi-Aventis and Microsoft: AventisMicrosoft.pdf (791 KB) Ole Nilssen: Nilssen.pdf (1608 KB) Amici Briefs filed in Support of Neither Party Apotex: Apotex.pdf (904 KB)  United States Patent & Trademark Office (USPTO): USPTO.pdf (770 KB) Intellectual Property Owners Association… [read post]